Company|BAT Invests in Expansion of Italian Factory, Adding 16 Production Lines for Heated Tobacco and Nicotine Pouches

Sep.15.2025
Company|BAT Invests in Expansion of Italian Factory, Adding 16 Production Lines for Heated Tobacco and Nicotine Pouches
BAT Italy will expand its Trieste plant, adding 16 new production lines for heated tobacco cartridges, nicotine pouches, and nicotine replacement therapy products. The expansion adds 6,300 m² of space, bringing the total to 30,000 m². This is part of BAT’s €500 million five-year investment plan launched in 2023.

Key Points:

 

·Expansion and Recruitment: BAT Italy is adding 16 new production lines at its Trieste production site and plans to hire 150 professionals by 2026.

·Product Positioning: The new production lines will focus on new nicotine products, including heated tobacco cartridges (for the Italian market only), while also expanding production capacity for oral nicotine pouches (sold to 16 European countries) and nicotine replacement therapy (NRT) products.

·Site Expansion: A new 6,300 square meters of production area will be added, and the expanded recycling warehouse will bring the total area to 30,000 square meters, tripling the original planned area.

·Employment and Positions: The project is part of BAT Italy's five-year plan announced in 2024 and is expected to create 2,700 jobs, primarily in manufacturing and engineering.

·Investment Background: The expansion is part of a five-year €500 million investment plan launched in 2023. By 2024, BAT had invested 168 million euros in Italy, created an output value of 30 million euros, and made a profit of 1.6 million euros, all of which had been reinvested in development.

 


 

2Firsts, September 15, 2025 - According to reports from ticonsiglio and ilsole24ore, British American Tobacco (BAT) Italy plans to hire 150 new positions at its Trieste production site through expansion and the introduction of new production lines.

 

BAT Italy has added 16 production lines to the site and expects to complete the recruitment of 150 professionals by 2026.

 

The expansion will be entirely dedicated to the production of new nicotine products, including heated tobacco cartridges, which users can use with specialized heated tobacco devices. These products will be sold exclusively in Italy.

 

These new production lines will also join existing lines for the production of oral nicotine pouches (currently sold in Italy and 15 other European countries) and the recently commissioned production line for nicotine replacement therapy (NRT) products. The expansion will add an additional 6,300 square meters, including the reuse of a disused warehouse in Trieste's Cargo Village, bringing the total area to 30,000 square meters: triple the original industrial plan's 10,000 square meters.

 

As part of its annual plan, BAT Italy announced in 2024 that it would create 2,700 jobs over the next five years. The majority of these future positions are expected to be in the production and manufacturing sector, encompassing roles such as production operators, equipment maintenance, quality control, technicians, engineers, and production process coordinators.

 

The expansion is part of a five-year, €500 million investment plan launched in 2023. According to data analysis, BAT invested €168 million in 2024 alone, generating €30 million in output. Profits reached €1.6 million in the previous fiscal year, all of which were invested in company development.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Michael Olise’s World Cup Locker-Room Photo Puts Nicotine Pouches in the Sports Business Spotlight
Michael Olise’s World Cup Locker-Room Photo Puts Nicotine Pouches in the Sports Business Spotlight
Several European sports outlets have reported on a suspected nicotine pouch seen in French footballer Michael Olise’s locker photo, bringing football’s long-running “snus” culture back into public view and highlighting brand visibility, product classification and public-health debate around nicotine pouches in sports settings.
News
Jun.25 by 2Firsts Perspectives
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
RLX Technology’s Q1 net revenues rose 96.2% year over year, with international business accounting for 72.3% of total revenue. Beyond the headline growth, the results point to deeper globalization: European operations, Nexus supply-chain integration and a broader product portfolio are becoming key signals to watch.
Special Report
May.20
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
InterTabac 2026: First conference program highlights now available online
InterTabac 2026: First conference program highlights now available online
With three months to go before the international tobacco and nicotine industry gathers again in Dortmund, InterTabac, together with NUBIZ and InterSupply, is set to bring around 800 exhibitors from across the globe to eleven exhibition halls. The three events will showcase innovation, market trends and industry networking, while the first conference program highlights are now online, offering trade visitors keynotes, panel discussions and masterclasses to support business decision-making.
Events
Jun.22
VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
Philip Morris Korea has officially launched its VEEV e-vapor brand in South Korea, introducing both the VEEV inPRIME device and VEEBI inPRIME pods. The launch further expands PMI’s smoke-free portfolio in Korea, alongside its IQOS heated tobacco products and ZYN nicotine pouches.
Jun.16